Edited by B. Timothy Walsh, M.D.
Series Editors: John M. Oldham, M.D., M.S., and Michelle B. Riba, M.D., M.S.
- 200 Pages
- Editorial Reviews
- ISBN 978-0-88048-833-4
- Item #8833
Child Psychopharmacology tackles the ongoing debate over the use of psychotropic medication on child and adolescent disorders. This book reviews the most up-to-date research on the topic and offers practical guidance for treating patients. Some points of interest in this volume include:
- Discussion of exciting new evidence that OCD may be secondary to betahemolytic streptococcal infections.
- Thorough coverage of both the benefits and side effects of antipsychotic medications including recent research on clozapine and olanzapine.
- Thoughtful academic treatment of the effectiveness of antidepressant medications, such as fluxetine, for treating adolescent bulimia.
In a field of study that is controversial and ever changing, Child Psychopharmacology is an invaluable reference. Covering both pharmacological and therapeutic treatment for young patients, this volume addresses these topics with thorough research and care.
- Foreward. Tic disorders and obsessive-compulsive disorder. Attention-deficit/hyperactivity disorder. Children and adolescents with psychotic disorders. Affective disorders in children and adolescents: a critical clinically relevant review. Anxiety disorders. Eating disorders. Afterword. Index.
About the Authors
B. Timothy Walsh, M.D., is William and Jay Ruane Professor of Psychiatry at Columbia University College of Physicians and Surgeons, New York, New York.
Thus this relatively concise text presents current evidence on the pharmacological management of a number of childhood conditions, and to a number of important areas of controversy. It is thus recommended for all medical practitioners prescribing pharmacological agents for children and adolescents.—Journal of Pediatric Child Health
Divided into six chapters. . . each written by an expert in the field, the overall feel to this book is one of brevity and an emphasis on what we need to know in order to best inform clinical practice. . . . This book is an excellent, concise and just about up-to-date summary of the use of psychopharmacological agents in children. It provides precise guidelines for practice where they exist and cautions where knowledge is lacking. Its brevity means that it can be read in a few hours. It is an essential read for all psychiatrists and trainee psychiatrists dealing with children and adolescents and the pediatricians and general practitioners who prescribe psychotropic drugs like methylphenidate or antidepressants to children.—Irish Journal of Psychological Medicine
[T]he writing is clear and succinct, and the information and references up-to-date. . . . The book is to be highly recommended.—Readings: A Journal of Reviews and Commentary in Mental Health
As a training director I found Child Psychopharmacology a veritable gold mine of valuable information, edited by B. Timothy Walsh. The six chapters provide a state-of-the-art critique of current studies in pharmacological interventions with children and adolescents. It is obvious that there is far more unknown than is known about the efficacy of drugs for childhood conditions. All the available data are presented, warts and all. A brief review of the current research literature is provided by each author with thoughtful recommendations for clinicians. Dr. Walsh has also integrated the disparate chapters such as Anxiety Disorders by Pine and Grun and Affective Disorders by Kutcher into a seamless whole, a feat most editors would envy. I recommend this book to serious child and adolescent psychiatrists at every level of training or experience.—Clarice J. Kestenbaum, M.D., Director of Training, Department of Psychiatry, Division of Child and Adolescent Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York
Child Psychopharmacology, edited by Timothy Walsh, is an up-to-date, informative, and highly readable review of drug treatment for the major child psychiatric disorders. Researchers and clinicians will both be impressed. This is a reference that practitioners should have on their desk.—Judith L. Rapoport, M.D., Chief, Child Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland